ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

NCT07454226 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Ph-Like
Acute Lymphoblastic Leukemia

Interventions

DRUG: Olverembatinib
DRUG: Gecacitinib
DRUG: Venetoclax
DRUG: Chemotherapy Regimen
DRUG: Blinatumomab
PROCEDURE: CAR-T Cell Therapy
PROCEDURE: Allogeneic HSCT

Sponsor

Institute of Hematology & Blood Diseases Hospital, China